Skip to main content
AAPS Open
Fig. 6 | AAPS Open

Fig. 6

From: PEGylated magnetic nanographene oxide for targeted delivery of arsenic trioxide and sec-o-glucosylhamaudol in tumor treatment with improved dual-drugs synergistic effect

Fig. 6

In vivo tumor inhibitory effects on HepG2 xenograft tumors. a Tumor volumes were measured every three days. Compared to PBS group, ***p < 0.001; compared to magnet + PEG@MGO@ATO group, #p < 0.05. b Weight of tumors of each therapeutic group after 18 days of treatments. Compared to PBS group, ***p < 0.001. **p < 0.01; compared to ATO group, ##p < 0.01. ###p < 0.001. c The body weight of mice in treatments. d The optical image of the excised tumor tissues after 18 days of treatments. e The H&E analysis for different groups (scale bar: 50 μm)

Back to article page